In recent years, with the continuous development of life science research, people have a detailed understanding of stem cells. Research achievements related to stem cells are playing an increasingly vital role in disease treatment, regenerative medicine and other fields.

 

Now, stem cell research has been included in the national key sci-tech research and development plan of the 14th Five-Year Plan (2021-2025). 

 

Hunan Binze Biotechnology Group is a biotech company that integrates the development of medical testing technologies and clinical application technologies, including cell technology R&D and application, genetic testing, disease warning and screening. 

 

 

 

Hunan Zhongke Binze Cell Biotechnology Co., Ltd. is jointly built by Hunan Binze Biotechnology Group and Zhongke Juyan Stem Cell Co., Ltd.

 

The first phase of the project will build a Chenzhou regional cell preparation center, a comprehensive cell bank, a cGMP standard production and R&D base, and a synthetic bioengineering research center. By carrying out precise prevention, diagnosis and treatment such as cell storage and cell technology research and development, advanced biotechnology health management will be provided to the public.